Form 8-K - Current report:
SEC Accession No. 0001798749-24-000042
Filing Date
2024-07-08
Accepted
2024-07-08 08:00:45
Documents
15
Period of Report
2024-07-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240708x8k.htm   iXBRL 8-K 46457
2 EX-99.1 tmb-20240708xex99d1.htm EX-99.1 7653
3 GRAPHIC tmb-20240708xex99d1001.jpg GRAPHIC 5633
  Complete submission text file 0001798749-24-000042.txt   190403

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20240708.xsd EX-101.SCH 3122
5 EX-101.LAB tmb-20240708_lab.xml EX-101.LAB 16576
6 EX-101.PRE tmb-20240708_pre.xml EX-101.PRE 10778
17 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240708x8k_htm.xml XML 4990
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 241103384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)